CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
24991-47-7 | 聚(4-氯苯乙烯) | Poly(4-chlorostyrene); Styrene,p-chloro-, homopolymer (6CI); Styrene, p-chloro-, polymers (8CI); 4-Chlorostyrene homopolymer; 4-Chlorostyrene polymer; Atacticpoly(p-chlorostyrene); Poly(4-chlorostyrene); Poly(p-chlorostyrene); p-Chlorostyrene homopolymer; p-Chlorostyrene polymer | (C8H7Cl)n | 详情 | 供应商 | |
68919-17-5 | C12-20-碳氢的化合物催化烷基化副产物 | Hydrocarbons, C12-20-catalytic alkylation by-products; Heavy alkylate hydrocarbons; hydrocarbons, c12-20, catalytic alkylation by-products; alkylated aromatic petroleum oil; alkylatedaromaticpetroleumoil; Hydrocarbons,C12-20-catalytic alkylation by-products | 无 | 详情 | 供应商 | |
91917-63-4 | 人α-ANF(I-28) | Atrial natriureticpeptide-28 (human reduced) (9CI); Atriopeptin-33(rat reduced), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-; 13: PN: WO2004089280 SEQID: 13 unclaimed sequence; 13: PN: WO2005103087 SEQID:16 unclaimed sequence; 140: PN: WO2008058016 SEQID: 141 claimed protein; 15:PN: US20030119021 SEQID: 14 unclaimed sequence; 15: PN: WO2008154226 SEQID: 15unclaimed protein; 16: PN: WO0071576 SEQID: 16 unclaimed sequence; 18: PN:WO2004022003 SEQID: 4 claimed sequence; 18: PN: WO2005094420 SEQID: 4 claimedsequence; 19: PN: WO2007034498 SEQID: 18 unclaimed sequence; 1: PN: DE19942230SEQID: 6 claimed protein; 1: PN: US20030069186 SEQID: 5 unclaimed sequence; 1:PN: US20090163421 SEQID: 1 unclaimed sequence; 1: PN: WO0185945 SEQID: 1unclaimed sequence; 2145: PN: WO03060071 SEQID: 2207 unclaimed; 21: PN:WO2004045592 SEQID: 20 unclaimed sequence; 220: PN: US20060293232 PAGE: 14unclaimed sequence; 294: PN: WO0069900 SEQID: 476 unclaimed sequence; 2: PN:GB2403533 SEQID: 2 claimed sequence; 2: PN: WO02074234 FIGURE: 3B claimedprotein; 301: PN: US20080004206 SEQID: 302 unclaimed protein; 313: PN:WO0069900 SEQID: 495 unclaimed sequence; 38: PN: WO2005003296 SEQID: 309unclaimed sequence; 393: PN: US20090175821 SEQID: 476 claimed protein; 3: PN:CN1278007 SEQID: 5 unclaimed sequence; 3: PN: US20080194481 SEQID: 302 claimedprotein; 439: PN: US20080312157 SEQID: 456 unclaimed sequence; 4: PN:US20080214437 SEQID: 4 claimed protein; 4: PN: WO2009073527 SEQID: 4 claimedprotein; 4: PN: WO2009142307 SEQID: 100 claimed protein; 5-32-Urodilatin(human); 59: PN: US6033884 SEQID: 53 unclaimed protein; 5: PN: WO2007035600SEQID: 3 unclaimed sequence; 604: PN: WO2009058322 SEQID: 302 claimed sequence; 78: PN: WO03099862 PAGE: 45 unclaimed protein; 7: PN: US20060183154 SEQID: 7claimed sequence; 95: PN: WO2007047504 SEQID: 179 unclaimed sequence; 99-126-natriuretic hormone peptide (human); 9: PN: US20010027181 SEQID: 1unclaimed protein; Atriopeptin-28 (Canis familiaris reduced); | C127H205N45O39S3 | 详情 | 供应商 | |
118691-41-1 | Atrial natriureticpeptide-24 (Rana catesbeiana reduced) (9CI); Atriopeptin-21(rat reduced), 2a-endo-L-aspartic acid-6-L-serine-17-L-methionine-20-glycine-21-L-arginine-21a-L-arginine-21b-L-phenylalanine-; 286: PN: WO0069900 SEQID: 468 unclaimed sequence; 289: PN: WO0069900 SEQID: 471unclaimed sequence; 386: PN: US20090175821 SEQID: 468 claimed protein; 3: PN:US20010027181 SEQID: 5 unclaimed sequence; L-Phenylalanine, L-seryl-L-seryl-L-a-aspartyl-L-cysteinyl-L-phenylalanylglycyl-L-seryl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-methionylglycyl-L-cysteinylglycyl-L-arginyl-L-arginyl- | C103H167N37O34S3 | 详情 | 供应商 | ||
118473-55-5 | Atrial natriureticpeptide-29 (chicken reduced) (9CI); Atriopeptin-29(chicken reduced); 283: PN: WO0069900 SEQID: 465 unclaimed sequence; 383: PN:US20090175821 SEQID: 465 claimed protein; 5: PN: US20010027181 SEQID: 8unclaimed sequence; L-Asparagine, L-methionyl-L-methionyl-L-arginyl-L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-methionylglycyl-L-cysteinyl-L-asparaginylglycyl-L-seryl-L-arginyl-L-lysyl-; a-Atriopeptin (chicken reduced) | C124H213N47O40S5 | 详情 | 供应商 | ||
153723-34-3 | Axinastatin 2 (9CI); Axinastatin1, 5-L-leucine-; 1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine, cyclicpeptide deriv.; Cyclo(L-asparaginyl-L-prolyl-L-phenylalanyl-L-valyl-L-leucyl-L-prolyl-L-valyl) | C39H58N8O8 | 详情 | 供应商 | ||
127785-71-1 | Aureobasidin M (9CI); AureobasidinA, 3-L-phenylalanine-8-(N-methyl-L-valine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine, cyclicpeptide deriv.; Antibiotic R 106XI; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-prolyl]; L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C59H90N8O10 | 详情 | 供应商 | ||
220305-84-0 | Adenopeptin (9CI); AntibioticpF 1201; Isovalinamide, 1-acetylprolylisovalylisovalyl-b-alanylglycyl-2-methylalanyl-2-methylalanylisovalyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-2-piperidinecarbonyl-N-[1-[(2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidinium-1-yl)methyl]-3-methylbutyl]- | C71H123N16O14+ | 详情 | 供应商 | ||
153723-35-4 | Axinastatin 3 (9CI); Axinastatin1, 4-L-isoleucine-5-L-leucine-; 1H-Dipyrrolo[1,2-a:1',2'-j][1,4,7,10,13,16,19]heptaazacycloheneicosine, cyclicpeptide deriv.; Cyclo(L-asparaginyl-L-prolyl-L-phenylalanyl-L-isoleucyl-L-leucyl-L-prolyl-L-valyl) | C40H60N8O8 | 详情 | 供应商 | ||
89106-96-7 | Atrial natriureticpeptide-21 (rat reduced) (9CI); Atriopeptin-21(rat reduced); 301: PN: WO0069900 SEQID: 483 unclaimed sequence; 400: PN:US20090175821 SEQID: 483 claimed protein; L-Serine,L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl- | C83H137N29O30S2 | 详情 | 供应商 | ||
152406-36-5 | Arthrofactin (9CI); L-Asparticacid, N-[N-[N-[N-[N-[N-[N-[N-[N-[N-[N-(3-hydroxy-1-oxodecyl)-D-leucyl]-D-a-aspartyl]-D-threonyl]-D-leucyl]-D-leucyl]-D-seryl]-L-leucyl]-D-seryl]-L-isoleucyl]-L-isoleucyl]-,l1-lactone; 1-Oxa-4,7,10,13,16,19,22,25,28,31,34-undecaazacycloheptatriacontane, cyclicpeptide deriv.; Cyclo(L-a-aspartyl-3-hydroxydecanoyl-D-leucyl-D-a-aspartyl-D-threonyl-D-leucyl-D-leucyl-D-seryl-L-leucyl-D-seryl-L-isoleucyl-L-isoleucyl) | C64H111N11O20 | 详情 | 供应商 | ||
13117-60-7 | Adenosine,N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate); Butyramide,N-(9-b-D-ribofuranosyl-9H-purin-6-yl)-,cyclic hydrogen phosphate (8CI); 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin,adenosine deriv.; Cyclic N6-monobutyryladenosine-3',5'-monophosphate; Monobutyryl adenosine cyclic 3',5'-monophosphate; N6-Butyryl cyclic AMP; N6-Butyryl-3',5'-cyclic AMP; N6-Butyryl-cAMP; N6-Butyryladenosine 3',5'-cyclicphosphate; N6-Monobutyryl 3',5'-cyclic AMP; N6-Monobutyryl cyclic AMP; N6-Monobutyryl-cAMP; N6-Monobutyryladenosine 3',5'-cyclic monophosphate; N6-Monobutyryladenosine-3',5'-cyclic monophosphoric acid | C14H18N5O7P | 详情 | 供应商 | ||
547-56-8 | Benzenesulfonic acid,4-hydroxy-, copper(2+) salt (2:1); Benzenesulfonicacid, p-hydroxy-, copper(2+) salt (2:1) (8CI); Cupriaseptol; Cupricp-phenolsulfonate | C6H6O4S.1/2Cu | 详情 | 供应商 | ||
39718-99-5 | Benzoic acid, 4-nitro-,2-phenylhydrazide; Benzoicacid, p-nitro-, 2-phenylhydrazide (6CI); 4-Nitrobenzoic acid phenylhydrazide; NSC 406774; p-Nitrobenzoic acid phenylhydrazide; p-Nitrobenzoicphenylhydrazide; b-p-Nitrobenzoylphenylhydrazine | C13H11N3O3 | 详情 | 供应商 | ||
119320-26-2 | Brain natriureticpeptide-32 (swine reduced) (9CI); Natriureticfactor-26 (pig brain reduced),N-[N2-[N-[N-[N2-(1-L-seryl-L-prolyl)-L-lysyl]-L-threonyl]-L-methionyl]-L-arginyl]-; 330: PN: WO0069900 SEQID: 512 unclaimed sequence; 425: PN: US20090175821 SEQID:512 claimed protein; 45: PN: US6028055 SEQID: 45 unclaimed sequence; 4: PN:US20010027181 SEQID: 6 unclaimed sequence; 6: PN: US20060051825 SEQID: 4unclaimed sequence; L-Tyrosine,L-seryl-L-prolyl-L-lysyl-L-threonyl-L-methionyl-L-arginyl-L-a-aspartyl-L-serylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-arginyl-L-arginyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-leucyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-valyl-L-leucyl-L-arginyl-L-arginyl-; Natriuretic factor-32 (pig brain reduced) | C149H252N52O44S3 | 详情 | 供应商 | ||
15005-62-6 | Bottromycin A2(7CI,9CI); BottromycicA2 acid, methyl ester; Pyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine, cyclicpeptide deriv.; I 337B; Stereoisomer of cis-3-methyl-L-prolyl-L-valyl-N1-(carboxymethyl)-3-methylvalinimidoyl-3-methylvalyl-b-methylphenylalanyl-3-(2-thiazolyl)-b-alanine 6-methyl ester cyclic (3® 1)-peptide | C42H62N8O7S | 详情 | 供应商 | ||
100364-58-7 | Cyclosporin A,6-[(2E,5R,6R,7S)-6-hydroxy-5-methyl-7-(methylamino)-2-octenedioic acid]-; CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanedioicacid]-; 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclicpeptide deriv.; AM 1A; Cyclosporin A metabolite 203-218; M 203-218 | C62H109N11O14 | 详情 | 供应商 | ||
3022-92-2 | Cyclo(D-cysteinyl-D-cysteinyl-L-valyl-D-leucyl-L-isoleucyl),cyclic (1®2)-disulfide; MalforminA (7CI,8CI); 15,16-Dithia-2,5,8,11,19-pentaazabicyclo[11.4.2]nonadecane, cyclicpeptide deriv.; Malformin A1 | C23H39N5O5S2 | 详情 | 供应商 | ||
89270-28-0 | Cyclosporin A,6-[(2S,3R,4R,6E)-3,8-dihydroxy-4-methyl-2-(methylamino)-6-octenoic acid]-; CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoicacid]-; 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclicpeptide deriv.; 7: PN: US6686454 SEQID: 7 claimed protein; AM 1; AM 1(peptide); Cyclosporin A metabolite 17; Cyclosporin AM 1; Cyclosporinmetabolite 17; M 17; OL 17 | C62H111N11O13 | 详情 | 供应商 | ||
19372-21-5 | Diphosphoric acid,copper(2+) salt (1:?); Diphosphoricacid, copper(2+) salt (9CI); Pyrophosphoric acid, copper(2+) salt (8CI); Cupricpyrophosphate | Cu2O7P2 | 详情 | 供应商 |